Clinical trials
Tuberculosis trials in Uganda
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
88 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2006 | 2 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 11 |
| 2020 | 8 |
| 2021 | 8 |
| 2022 | 8 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 55 |
| Recruiting | 10 |
| Unknown status | 10 |
| Not yet recruiting | 5 |
| Active, not recruiting | 5 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of California, San Francisco | 12 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 9 |
| Makerere University | 8 |
| Centers for Disease Control and Prevention | 6 |
| Institut National de la Santé Et de la Recherche Médicale, France | 5 |
| Global Alliance for TB Drug Development | 4 |
| ANRS, Emerging Infectious Diseases | 3 |
| Epicentre | 3 |
| Mbarara University of Science and Technology | 3 |
| University of Liverpool | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tuberculosis | 88 |
| Acquired Immunodeficiency Syndrome | 14 |
| Tuberculosis, Pulmonary | 12 |
| HIV Infections | 11 |
| Latent Tuberculosis | 6 |
| Tuberculosis, Multidrug-Resistant | 6 |
| Disease | 4 |
| Diabetes Mellitus | 2 |
| Pneumonia | 2 |
| Sepsis | 2 |
Trials
Showing 76 to 88 of 88. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.